Literature DB >> 2173622

High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor beta.

M Reiss1, E B Stash.   

Abstract

Transforming Growth Factor beta is a potent autocrine inhibitor of the growth of untransformed keratinocytes. We found each of eight human squamous carcinoma cell lines to be refractory to the anti-proliferative action of Transforming Growth Factor beta. Although each of these carcinoma cell lines expressed the 53-65 kDa (type I) and the 280-300 (type III) Transforming Growth Factor beta-receptor proteins, the 73-85 kDa (type II) species was detectable in only one of these cell lines. Furthermore, although Transforming Growth Factor beta-sensitive non-neoplastic mouse keratinocytes expressed type II binding proteins, human keratinocytes did not. Our findings suggest that resistance to the growth-inhibitory actions of Transforming Growth Factor beta is a common feature of human squamous carcinoma cell lines but does not correlate with the expression of cell-surface receptors for this growth factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173622     DOI: 10.3727/095535490820874029

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  10 in total

1.  Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.

Authors:  A Franchi; O Gallo; I Sardi; M Santucci
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

2.  Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait.

Authors:  M Reiss; T Muñoz-Antonia; J M Cowan; P C Wilkins; Z L Zhou; V F Vellucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 3.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 4.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

5.  Aberrant expression of p-Smad3 in oral carcinogenesis.

Authors:  Sopee Poomsawat; Jirapa Punyasingh; Paisarn Vejchapipat
Journal:  Clin Oral Investig       Date:  2014-07-19       Impact factor: 3.573

6.  Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.

Authors:  Wanglong Qiu; Frank Schönleben; Xiaojun Li; Gloria H Su
Journal:  Cancer Lett       Date:  2006-02-14       Impact factor: 8.679

7.  TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.

Authors:  C Freudlsperger; Y Bian; S Contag Wise; J Burnett; J Coupar; X Yang; Z Chen; C Van Waes
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

8.  Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.

Authors:  Tania Fernandez; Stephanie Amoroso; Shellyann Sharpe; Gary M Jones; Valery Bliskovski; Alexander Kovalchuk; Lalage M Wakefield; Seong-Jin Kim; Michael Potter; John J Letterio
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

Review 9.  Divide and conquer: two stem cell populations in squamous epithelia, reserves and the active duty forces.

Authors:  Spencer Dunaway; Alexandra Rothaus; Yuhang Zhang; Ana Luisa Kadekaro; Thomas Andl; Claudia D Andl
Journal:  Int J Oral Sci       Date:  2019-08-27       Impact factor: 6.344

10.  Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro.

Authors:  J R Werkmeister; E A Blomme; M T Weckmann; A Gröne; L K McCauley; A B Wade; J O'Rourke; C C Capen; T J Rosol
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.